These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. NK Cell Subtypes as Regulators of Autoimmune Liver Disease. Jiao G; Wang B Gastroenterol Res Pract; 2016; 2016():6903496. PubMed ID: 27462349 [TBL] [Abstract][Full Text] [Related]
4. NK cell subsets in autoimmune diseases. Zhang C; Tian Z J Autoimmun; 2017 Sep; 83():22-30. PubMed ID: 28285736 [TBL] [Abstract][Full Text] [Related]
5. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Reiter Z Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640 [TBL] [Abstract][Full Text] [Related]
7. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity? Zhang C; Zhang J; Wei H; Tian Z Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316 [TBL] [Abstract][Full Text] [Related]
8. Teleost T and NK cell immunity. Fischer U; Koppang EO; Nakanishi T Fish Shellfish Immunol; 2013 Aug; 35(2):197-206. PubMed ID: 23664867 [TBL] [Abstract][Full Text] [Related]
9. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761 [TBL] [Abstract][Full Text] [Related]
11. Human NK cell education by inhibitory receptors for MHC class I. Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727 [TBL] [Abstract][Full Text] [Related]
12. Licensing of natural killer cells by self-major histocompatibility complex class I. Yokoyama WM; Kim S Immunol Rev; 2006 Dec; 214():143-54. PubMed ID: 17100882 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
14. NK cell subsets and their role in allergy. Deniz G; Akdis M Expert Opin Biol Ther; 2011 Jul; 11(7):833-41. PubMed ID: 21426239 [TBL] [Abstract][Full Text] [Related]
15. Mutual interference of HIV and natural killer cell-mediated immune response. Jacobs R; Heiken H; Schmidt RE Mol Immunol; 2005 Feb; 42(2):239-49. PubMed ID: 15488611 [TBL] [Abstract][Full Text] [Related]
16. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Kumar V; McNerney ME Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099 [TBL] [Abstract][Full Text] [Related]
17. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Thielens A; Vivier E; Romagné F Curr Opin Immunol; 2012 Apr; 24(2):239-45. PubMed ID: 22264929 [TBL] [Abstract][Full Text] [Related]
18. Structural insights into activation of antiviral NK cell responses. Finton KA; Strong RK Immunol Rev; 2012 Nov; 250(1):239-57. PubMed ID: 23046134 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional control of natural killer cell development and function. Hesslein DG; Lanier LL Adv Immunol; 2011; 109():45-85. PubMed ID: 21569912 [TBL] [Abstract][Full Text] [Related]
20. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]